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ABSTRACT Chronic obstructive pulmonary disease (COPD) care across Europe has high heterogeneity
with respect to cost and the services available. Variations in length of stay (LOS) may be attributed to patient
characteristics, resource and organisational characteristics, and/or the so-called hospital cluster effect.
The European COPD Audit in 13 countries included data from 16018 hospitalised patients. The
recorded variables included information on patient and disease characteristics, and resources available.
Variables associated with LOS were evaluated by a multivariate, multilevel analysis.
Mean±SD LOS was 8.7±8.3 days (median 7 days, interquartile range 4–11 days). Crude variability
between countries was reduced after accounting for clinical factors and the clustering effect. The main
factors associated with LOS being longer than the median were related to disease or exacerbation severity,
including GOLD class IV (OR 1.77) and use of mechanical ventilation (OR 2.15). Few individual resource
variables were associated with LOS after accounting for the hospital cluster effect.
This study emphasises the importance of the patients’ clinical severity at presentation in predicting LOS.
Identifying patients at risk of a long hospital stay at admission and providing targeted interventions offers
the potential to reduce LOS for these individuals. The complex interactions between factors and systems
were more important that any single resource or organisational factor in determining differences in LOS
between hospitals or countries.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a condition with high morbidity and cost to health
services. Hospitalisations due to COPD negatively affect the well-being of patients with an impact on
length and quality of life. Studies in different European countries have highlighted the cost of the disease
and that of admissions. In a survey conducted in 1998–1999, annual direct expenditure for COPD
treatment per patient in Europe ranged from €530 in France to €3238 in Spain [1] with a significant
proportion of this cost due to inpatient treatment of exacerbations [1, 2]. Accordingly, several initiatives
have been proposed to reduce the number of hospitalisations or to reduce the length of stay (LOS) from a
cost-effectiveness and clinical perspective [3–5].
Various factors have been implicated in increasing LOS of hospital admissions, both clinical [6–10] and
social [11]. European health systems have a large inter-hospital variability in terms of resources and the
range of services offered [12, 13], and some previous reports have found a relationship between LOS and
such factors [4, 14, 15], whilst others have not [16, 17]. To our knowledge, there has been no comprehensive
analysis studying the effects of clinical, organisational and resource factors on LOS in European patients
admitted with exacerbations of COPD across a range of European countries and healthcare systems.
The European COPD Audit was a European Respiratory Society (ERS)-funded project designed as a pilot
study, performed in 2010–2011 to evaluate clinical practice variability as well as clinical and organisational
factors related to outcomes for COPD hospital admissions across Europe, in which 432 hospitals from
13 European countries participated including 16018 cases of COPD exacerbations admitted to hospital.
In the present analysis, we aimed to determine the mean LOS across Europe and determine the degree of
variability to test the hypothesis that these variations in LOS may be attributed to either patient
characteristics or the organisational and resource characteristics, and determine the relative importance of
these factors. We also hypothesised that LOS may be influenced by the hospital cluster effect, which indicates
that patients with similar characteristics may experience different processes of care and outcomes, depending
on the hospital to which they are admitted. These include a wide range of complex factors not easily
measured that might influence clinical care including local guidelines and policies, practices of individual
clinicians, the admission policy, cultural practices that may influence the decision whether to admit or
discharge patients, or clinical characteristics that may be observed within geographical clusters. These include
factors common to the local population, such as socio-demographics, family and social support networks,
cultural beliefs and attitudes, and environmental susceptibilities. Such effects on patient outcomes, although
not measured individually, can be combined in a theoretical statistical model as the cluster effect to explain
residual variation once the factors that have been measured have been accounted for.
Methods
The study design and the methodology of the European COPD Audit have been extensively described
elsewhere [18]. Briefly, this ERS-funded COPD audit was designed as a pilot study to evaluate clinical
practice variability as well as clinical, organisational and resource factors related to outcomes for COPD
hospital admissions in 13 countries across Europe (Austria, Belgium, Croatia, Greece, Ireland, Malta,
Poland, Romania, Slovakia, Spain, Switzerland, Turkey and the UK). It was designed as a prospective,
observational, non-interventional cohort trial.
The study comprised of a first 8-week phase during which all consecutive cases admitted to hospital for
greater than 12 h due to an exacerbation of COPD were identified. These were considered potential cases,
which were then confirmed as an exacerbation upon discharge, according to the diagnosis on the
discharge report. Information on clinical practice was gathered for these patients. Comorbidities were
recorded as a Charlson Comorbidity Index score, a validated measure of comorbidity status [19]. During
this period, participating hospitals were also asked to complete a cross-sectional survey of the resources
devoted to COPD acute care. Cases included had their medical history regarding the admission audited,
and they were followed-up for 90 days after the admission to evaluate readmissions and survival.
The ERS managed the audit and named a steering committee, which reported to the ERS Executive
Committee, to oversee the process. Items for the organisational and resource database were selected by the
steering committee, based upon those that had previously been used and validated in the Spanish and UK
national audits [20, 21]. The audit included questions related to the hospital and to the respiratory unit
resources separately. An item list of the final survey is available [18].
The study period comprised hospital admissions from October 25, 2010, to December 19, 2010, and from
January 3, 2011, until February 27, 2011, according to the seasonal COPD exacerbation peak of the
participating countries. As there is no European ethics committee for audits; national societies ensured
compliance with European and national ethical requirements, and all participants followed the European ethical
requirements for scientific studies. All partners of the project accepted the general ethical rules of the ERS.
ERJ Open Res 2016; 2: 00034‐2015 | DOI: 10.1183/23120541.00034-2015 2
COPD | M. RUPAREL ET AL.
A software company (IDCode, Lausanne, Switzerland) was commissioned to design a web-based collection
tool encompassing both the resource and organisational as well as clinical databases. The anonymised data
was entered remotely at each participating site to a centrally controlled server. The web tool was
established as a multilingual database, to allow the data to be documented in the language of each
participating country. The web tool provided a “help facility” with explanatory text to assist with
interpretation of the survey questions.
Data analysis
Statistical analysis was performed by a data-analysis team in Spain using Stata 12 (StataCorp LP, College
Station, TX, USA). Descriptive variables were summarised by using the mean±SD for quantitative variables
and the absolute (relative) frequencies for categorical ones.
Since LOS did not follow a normal distribution, the variables were characterised and those patients with a
LOS beyond the median were further studied. Associations of variables potentially associated with LOS were
tested by using a multivariable, multilevel logistic regression analysis for LOS longer than the median as the
dependent variable. Continuous variables were categorised in different strata in which a missing value was
considered one independent category. As part of an audit, missing information is also relevant. By
categorising missing values, it allowed us to control the effect of one missing piece of information in the
clinical performance. The only exceptions were age and Charlson index, which were not categorised since
there was no missing information in these variables. In this multilevel model, data are analysed considering
the hierarchical distribution of data, taking into consideration if the variables represent hospital characteristics
(level 1) or patient characteristics (level 2). These analyses were performed with the following assumptions:
1) the multilevel model assumes a hierarchical data structure with explanatory variables measured at both
hospital and patient levels; and 2) inter-hospital variation in the dependent variable was random.
In this analysis, we acknowledged that patients within the same hospital may receive similar care, which
might be different from the care they may receive in other hospitals for the same clinical situation. This is
so because patients within one hospital are subjected to distinct common contextual, hospital-linked
influences. Our hypothesis is that this different behaviour in the different participant hospitals, the
so-called hospital cluster effect, may influence LOS. Multivariable, multilevel regression analysis enables
quantification of this hospital cluster effect and provides unbiased estimates of the regression coefficients.
It can also concurrently include the predictor variables at both the patient level and hospital level. The
coefficients of the predictor variables were transformed into odds ratios with 95% confidence intervals.
In addition, the hospital cluster effect was evaluated and quantified by two indicators: 1) the intra-cluster
correlation coefficient (ICC) adapted to the logistic regression [22] and 2) the median odds ratio (MOR)
with 95% confidence intervals [23, 24]. The ICC quantifies the fraction of the total variability in the
outcomes attributable to the clustering effect. The ICC ranges from 0 to 1, and a lower ICC indicates a
smaller cluster effect. The MOR is a measure of cluster heterogeneity and is defined as the median value of
the distribution of odds ratios obtained when two individuals from different hospitals (i.e. one individual
from the highest LOS hospital and one individual from the lowest LOS hospital) were randomly selected
and compared. Simplified, the MOR can be interpreted as the median increased odds of reaching the
outcome if an individual was admitted to another hospital with a greater risk of that outcome. The measure
is always ⩾1, where the MOR equals 1 when there is no between-cluster variation and the MOR increases
as the variation becomes larger. Interestingly, the MOR is statistically independent of the prevalence of the
outcome, can be easily computed, and is directly comparable with the coefficients of the individual- and
hospital-level predictors. To plot the reduction in the between-hospital outcome variations after accounting
for the hospital cluster effect and the predictor variables, the crude estimates of probability were
transformed to the logit scale for comparisons, and cases with no LOS recorded were excluded.
For the multilevel analysis, we first fitted an “empty model” that only considered the clustering effect on
the variability of LOS, expressed as ICC and MOR. Backward selection was attempted; however, the data
did not converge in the multilevel analysis because of the high number of variables included so we opted
for the forward selection procedure, which provided a better fit. The “final model”, therefore, used a
forward selection procedure based on Wald tests results, added as covariates to the model those
“explanatory variables” associated with the outcome of interest in the bivariate analysis.
Various approaches to handle missing data were considered including analysis of the data without
considering the missing information. This was rejected as in the multivariable analysis, a large number of
cases would have been deleted due to missing values for different variables, which would have led to a
shorter and biased database. Imputation was also considered; however, again, it was felt that this would
result in a dataset that would again be artificial and not representative of our sample. Therefore, we
considered the “missing values” as an additional category of those variables.
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Results
During the study, 19150 cases were initially considered upon admission as potential cases. Of these, the
diagnosis of COPD exacerbation was confirmed by the lead investigator in that centre in 16018 cases upon
discharge. However, in 37 cases, the LOS was not possible to calculate due to lack of information. Thus, the
sample for the present analysis was 15981 patients. Mean±SD LOS was 8.7±8.3 days (median 7 days,
interquartile range 4–11 days). The crude distribution of the LOS between countries is presented in table 1
in the supplementary material. Of the analysed population, 6955 (43.4%) cases had a LOS longer than the
median. The description of the patient- and disease-related variables are summarised in table 1. The sample
of patients had high pack-year smoking histories (mean 47.2 pack-years). Forced expiratory volume in 1 s
was skewed towards more severe disease (mean 44% predicted) and a large proportion had features of
infection (50% had sputum colour change) or co-existent lung consolidation (18.5%). The organisational
variables within the sample varied significantly. Only 31.3% of units had an early supported discharge
service and 48.8% had access to a pulmonary rehabilitation service. The hospital size and the numbers of
respiratory specialist consultants, nurses, lung function technicians and physiotherapists varied greatly.
The bivariate analysis is summarised in the supplementary material (tables 1S and 2S). Resource and
organisational variables associated with an increased LOS beyond the median were size-related (hospital size
by number of beds or the number of pulmonologists), staff-related (having a respiratory team or the number
of lung function technicians) and performance-related (the percentage of patients seen by a physiotherapist or
the percentage of eligible patients included in a rehabilitation programme). Patient-related variables associated
with an increased LOS beyond the median were related to comorbidities, the severity of the exacerbations and
interventions given.
TABLE 1 Characteristics of the studied patients
Variable Value Intercountry range
Male sex 10865 (67.8) 47.3–86.0
Age years 70.7±10.7 63.4–72.7
Current smokers 5012 (31.3) 15.4–46.8
Tobacco history pack-years 47.2±31.2 29.8–70.8
Comorbidity
Charlson Comorbidity Index score 2.4±1.6 1.7–3.1
Cardiovascular disease 6491 (40.5) 32.4–71.4
Diabetes 3181 (19.9) 11.9–27.5
Neoplasms 1950 (12.2) 2.6–18.9
Body mass index kg·m−2 26.6±6.4 25.0–28.5
Admissions in previous 12 months 1.2 (1.8) 0.4–1.8
Spirometry
FVC % predicted 65.4±20.3 45.2–74.9
FEV1 % predicted 44.0±17.4 38.9–56.1
Previous GOLD spirometric classification
No spirometry available 6512±40.7 9.9–53.6
Spirometry with no obstruction 1226±7.7 3.2–34.0
Mild 195±1.2 0–3.0
Moderate 2175±13.6 2.7–31.0
Severe 3737±23.3 11.6–34.9
Very severe 2098±13.1 4.8–23.8
Missing 75±0.5 0–2.7
Dyspnoea increase 15409 (96.2) 92.5–100
Sputum increase 10373 (64.8) 49.2–79.0
Sputum colour change 8134 (50.8) 36.9–63.3
pH 7.39±0.07 7.37–7.41
PaCO2 kPa 6.4±2.1 5.7–7.0
PaO2 kPa 8.6±3.4 7.3–10.8
Chest radiography
Normal or COPD-like findings 8051 (50.3) 33.0–55.5
Consolidation 2969 (18.5) 8.9–32.6
Other findings 4752 (29.7) 16.7–58.0
Data are presented as n (%) or mean±SD, unless otherwise stated. FVC: forced vital capacity; FEV1: forced
expiratory volume in 1 s; GOLD: Global Initiative for Chronic Obstructive Lung Disease; PaCO2: arterial
carbon dioxide tension; PaO2: arterial oxygen tension; COPD: chronic obstructive pulmonary disease.
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The empty model exhibited a significant hospital cluster effect (ICC 0.18) and cluster heterogeneity (MOR
2.30). In essence, 18% of the variability was explained by clustering resulting in a 2.3-fold increased
association with LOS. The adjusted model retained a number of variables as outcome predictors, and
these were split into the five categories: 1) patient-related variables, 2) disease-related variables,
3) treatment-related variables, 4) exacerbation severity-related variables, and 5) resource-related variables;
and the odds ratios depicting the likelihood of the association are in table 2. The strongest relationships
were seen between advanced Global Initiative for Chronic Obstructive Lung Disease (GOLD) status
(OR 1.77 for GOLD class IV) and the use of mechanical ventilation (OR 2.15). The use of antibiotics and
the presence of consolidation on the chest radiography were also strongly associated with LOS (OR 1.46
and 1.27, respectively). Although there was a crude variability of LOS between the different countries, this
was reduced after accounting for these clinical factors and the clustering effect (figure 1). The graphical
representation of significant variables is depicted in figure 2.
Discussion
This study is a comprehensive analysis of factors associated with LOS for COPD patients admitted to
hospital with an exacerbation across Europe. Other clinically relevant outcomes including death and
readmissions have been previously published elsewhere [25]. The mean and median LOS across Europe
were higher than expected from previous studies in individual countries around Europe [10, 26] and
showed great variability. This is in keeping with a recent systematic review that showed consistently high
variability of COPD LOS across countries in Europe, North America and Australasia [27]. The variability
observed in the present study was, however, reduced when the hospital cluster effect (an important
consideration in reducing bias from intrinsic institutional factors not measured in the analysis [24]) was
accounted for. Clinical and patient factors were associated with LOS but resource and organisational
factors had less influence individually than expected from previous studies.
Patient-related factors
In contrast to previous studies [9, 28], the variables of an increase in Charlson index by 1 point, increasing
age and body mass index (BMI) classified as overweight or obese were not strongly associated with longer
LOS. However, there was a suggestion within the trend that those who had a low BMI (OR 1.13, 95% CI
0.97–1.33) were more likely to have a longer LOS. This is in accordance with previous studies
demonstrating that nutritional status is of importance in quality of life, respiratory muscle strength and
exercise capacity [29, 30], all factors which would affect recovery from an exacerbation. More recently, an
American study reported a reduction in LOS, readmission rate and hospitalisation cost associated with oral
nutritional supplementation and further studies evaluating this are needed [31].
Less anticipated was that current smoking status was also associated with a shorter LOS. This may be
attributed to the “healthy smoker effect” whereby smokers have less perception or greater tolerance of their
symptoms [32, 33]. Further to this, the desire for discharge may be enhanced by additional motivational
factors, such as a desire to smoke and therefore to mobilise earlier than ex-smokers. Though the present
study did not assess psychosocial factors which have been previously noted to impact LOS [11, 34], this
observed effect with smoking status may be related to such factors and should be further evaluated.
Disease and exacerbation severity-, and treatment-related factors
Disease and exacerbation severity-, and treatment-related factors were more strongly associated with a LOS
longer than the median, and of those, the biggest impact was noted with GOLD classification IV. This
finding is in keeping with previous reports [8, 35, 36]. A history of previous admissions was also associated
with longer LOS. This effect may be due to disease severity but is also likely to be impacted by psychosocial
factors. Certainly, an association between LOS, depression and early readmission has been reported [37].
Although severity scores for COPD exacerbation exist, such as BODE index [38], these were not recorded
as a variable in the present study. Therefore, other clinical features that occur in more severe episodes have
been evaluated and interpreted as surrogate markers of exacerbation severity.
Patients who were acidotic or had sputum purulence were also more likely to have an increased LOS (OR
1.25 and 1.11, respectively) as reported by previous studies in different populations [6–9].
The use of invasive ventilation was associated with increased LOS. In keeping with this is a report by
LIMSUWAT et al. [39], who also found intubation and mechanical ventilation was associated with increased
LOS. The use of antibiotics, theophylline and diuretics were also associated with an increased risk of a LOS
longer than the median. This may be attributed to a more severe episode, as such factors may be considered
surrogate markers of a more severe episode. However, this interpretation is subject to appropriate treatment
selection, and does not consider the potential increase in LOS caused by over-treatment that may result in
complications such as antibiotic-associated diarrhoea or oxygen-induced hypercapnic respiratory failure,
which may impact LOS.
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TABLE 2 Multivariate, multilevel analysis of factors associated with length of stay longer than the median
Variable Category OR (95% CI)
Patient-related variables
Age years 1.01 (1.01–1.02)
Smoking status Ex-smoker 1
Active 0.85 (0.78–0.93)
Never-smoker 0.94 (0.80–1.12)
Missing 1.08 (0.92–1.28)
Charlson Comorbidity Index score 1.04 (1.01–1.06)
Body mass index kg·m−2 <19.5 1.13 (0.97–1.33)
19.5–24.99 1
25–29.99 0.89 (0.79–1.00)
>29.99 0.88 (0.78–1.00)
Missing 0.83 (0.74–0.93)
Disease-related variables
Previous admissions No 1
Yes 1.15 (1.07–1.24)
Missing 1.11 (0.96–1.28)
GOLD stage 1 1
2 1.10 (0.79–1.55)
3 1.20 (0.86–1.67)
4 1.77 (1.25–2.49)
Missing 1.36 (0.97–1.90)
Exacerbation severity-related variables
pH <7.35 1.25 (1.12–1.40)
⩾7.35 1
Missing 1.04 (0.93–1.16)
Purulent sputum No 1
Yes 1.11 (1.03–1.20)
Missing 1.05 (0.91–1.20)
Consolidation No 1
Yes 1.27 (1.16–1.40)
Treatment-related variables
Invasive mechanical ventilation No 1
Yes 2.15 (1.25–3.72)
In-hospital antibiotics No 1
Yes 1.46 (1.30–1.64)
In-hospital methylxanthines No 1
Yes 1.22 (1.07–1.40)
In-hospital inhaled corticosteroids No 1
Yes 1.10 (1.01–1.20)
In-hospital diuretics No 1
Yes 1.36 (1.25–1.49)
Radiography performed No 1
Yes 1.42 (1.03–1.95)
Resources-related variables
Respiratory ward Yes 1
No 1.33 (1.22–1.45)
Missing 0.38 (0.11–1.32)
Number of respiratory specialists in unit <6 1
⩾6 1.19 (1.00–1.40)
Missing 0.68 (0.38–1.24)
Level Empty model Final model
Country Hospital Country Hospital
Intra-class correlation coefficient 0.11 0.19 0.12 0.21
Median odds ratio 0.19 2.31 1.94 2.42
GOLD: Global Initiative for Chronic Obstructive Lung Disease. Wald χ2 (35) 1006.00; log likelihood −9562.0768; probability that χ2>0.0000.
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Resource and organisational factors
Of the resource and organisational factors that were found to be associated with a LOS longer than the
median in the initial bivariate analysis, only two were retained in the final model. This was despite taking
a more conservative value for significance (p>0.1). In this analysis, no association was noted between LOS
in hospitals where early supported discharge service was available, where there was a respiratory consultant
available out of hours or where there were more than six respiratory consultants in the organisation,
contrasting with previous reports [4, 14]. Whilst in the UK, 75.2% of centres had an early supported
discharge service, in the rest of Europe, this figure declined to 15.4% and is likely to include a number of
different service models under that umbrella term.
Data from the UK COPD audit data from 2003 and 2008 [14, 26], very much support the implementation
of services such as early supported discharge programmes due to an observed reduction in LOS and these
reports suggested that units with more respiratory consultants and better quality organised care had lower
mortality and reduced LOS. Furthermore, a previous randomised controlled trial [4] also noted a dramatic
reduction in LOS from 6.1 to 3.2 days in a group of patients receiving care from an early supported
discharge service versus standard inpatient care. The explanation for our findings is unclear but may relate
to the relatively high LOS reported in this audit by the UK centres and the low level of this form of service
across Europe as a whole. Other studies have supported use of early supported discharge services in the
absence of a reduction in LOS [40–42] due to patient preference or positive impacts on patients’
well-being with use of such services.
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FIGURE 1 The variability of probability of that the length of stay is longer than the median by country. The black dots represent the logit of each
hospital a, b) accounting only for cluster effects without covariates and c) accounting for cluster effects and covariates. The green dots represent
the logit of each country. Logit is defined as the probability determined by logistic regression: logit(p)=log(p/1−p).
Active smoker
Odds ratio
Age
Charlson
BMI <19.5 kg·m–2
BMI <25–29.99 kg·m–2
BMI >29.99 kg·m–2
a)
Odds ratio
Non-respiratory ward
>6 respiratory specialists 
b)
Previous admissions
Odds ratio
GOLD II
GOLD III
GOLD IV
Purulent sputum
Presence of consolidation
pH <7.35
c)
IMV
Antibiotics given
Theophyllines
Steroids
Diuretics
Radiography performed
Odds ratio
d)
FIGURE 2 Odds ratios for a length of stay longer than the median of the variables retained in the final model.
Vertical dashed lines represent OR 1. BMI: body mass index; GOLD: Global Initiative for Chronic Obstructive
Lung Disease; IMV: invasive mechanical ventilation.
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This study has found that when resource and organisational factors are considered within a cluster model
their individual impact on length of stay is greatly diminished. In real-life situations, it is the complex
manner in which these various factors interact that determines outcomes for patients and that is reflected
in the cluster analysis. Further studies are needed to evaluate this complex interaction in more detail in
order to tease out the important influencing factors and to provide appropriate targets for improving
outcomes with relation to length of stay.
Strengths and limitations
The design of the study and statistical methods underwent a great deal of consideration. Other methods of
data analysis, including logit, Poisson, negative and polynomial regression, were rejected as it was felt that
the chosen methodology, which enabled accounting for factors that were not measured as outcomes, was
superior. Factors such as hospital admission policies, cultural practices, presence of family at home to care
for the discharged patients, weather, availability of beds, clinical practice styles, physician thresholds for
discharge and socio-demographic factors vary greatly across the countries in Europe included within this
audit, and all have an impact on LOS. As none of these was recorded in this study and many are difficult
to measure, the multi-level approach was considered ideal, as these factors would be incorporated within
the hospital cluster effect.
Use of such a model has obvious limitations in keeping with other mathematical models; for example, it
may over-account for factors, making some associations difficult to find. The aim, however, is to highlight
the most important and significant associations. Further studies are vital to evaluate the relative
importance of the factors found to be associated with LOS in this study and other factors that may be
encompassed within the hospital cluster effect that have not been measured.
Participation was on a voluntary basis, so there was no intention of representative sampling. The
heterogeneity of the study participants across multiple countries and the interpretation of study variables
by different investigators are likely additional limiting factors.
The diagnosis of exacerbation of COPD may be subject to interpretation, and by excluding patients who were
admitted for less than 12 h, we perhaps imposed a degree of selection bias into our population, and perhaps it
would be also interesting to evaluate those who presented to hospital but were discharged more quickly.
Missing data were a significant problem, as is often the case with retrospective audits. Various methods of
dealing this were considered, all of which posed their own problems. We acknowledge that the approach
utilised was not flawless, but we considered it the least problematic and, in most cases, the more amenable
to clinical interpretation.
Despite these limitations, the strengths of the present study, such as the wide European sampling and the
comprehensive statistical analysis of organisational and clinical variables by using a multilevel approach, is
highly informative and serves to eliminate biases associated with the clustering effect.
Conclusions
This study has shown that there is a wide observed variation in LOS across Europe. Some of this is likely to
be attributable to the different service models used in those countries. Patient and care process factors of
highest impact that were associated with increased LOS in this study were reduced BMI, advanced GOLD
classification, presence of respiratory acidosis, consolidation and the use of diuretics. Resource and
organisational factors such as size of hospital and the presence of early supported discharge service were not
key determinants of LOS after accounting for the clustering effect, whilst admission to a respiratory ward
remained an important factor. Identifying patients at risk of a long hospital stay at admission and providing
targeted interventions such as early mobilisation offers the potential to reduce LOS for these individuals.
Whilst there are a number of individual factors that affect the LOS of any one patient, it is not just the
presence of resources or services but the complex interactions of how a hospital functions to use those
resources and services effectively, or not, that is most important in determining the average LOS of a
cohort of admitted COPD patients. We suggest that future research should be targeted at identifying those
factors that optimise the organisational effectiveness of hospitals irrespective of the health service system
within which they operate.
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